clinicaladvisor.com

Standardized Definition of Mild to Moderate Ulcerative Colitis Needed

ulcerative colitis, inflammatory bowel disease, IBD, UC Researchers performed a systematic review of clinical trials to assess the need for a consensus on the definition of mild to moderate, active ...

MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis

MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases ...
Monthly Prescribing Reference

Guideline Issued for Treatment of Mild/Moderate Ulcerative Colitis

HealthDay News —A new clinical guideline from the American Gastroenterological Association (AGA) published December 18 in Gastroenterology focuses on the medical management of patients with ...
Business Wire

Landos Biopharma Announces First Patient Dosed in Global Phase 2 Clinical Trial of BT-11 in Mild to Moderate Ulcerative Colitis

Landos Biopharma Announces First Patient Dosed in Global Phase 2 Clinical Trial of BT-11 in Mild to Moderate Ulcerative Colitis - Global clinical trial underway in 11 countries, including U.S., ...
Healio

Curcumin shows promise for treatment of mild-to-moderate ulcerative colitis

Please provide your email address to receive an email when new articles are posted on . When combined with mesalamine therapy, curcumin, a natural phytochemical derived from turmeric, was superior to ...
Business Wire

UCERIS® (budesonide) 2mg Rectal Foam for the Induction of Remission of Mild-to-Moderate Distal Ulcerative Colitis Granted Tentative Approval by FDA

RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the FDA has granted tentative approval for UCERIS® (budesonide) rectal foam for the induction of ...
News Medical

AGA's new clinical guideline to help manage patients with mild-to-moderate ulcerative colitis

Most patients with ulcerative colitis (UC) have mild-to-moderate disease characterized by periods of activity or remission, but practice variations exist in disease management. A new clinical ...
Morningstar

Ferring Demonstrates Effectiveness of a Treat-to-Target Approach in Mild-to-Moderate Ulcerative Colitis in First Major Study

Ferring Pharmaceuticals today announces results from the OPTIMISE study showing the first real-world evidence of the effectiveness of a treat-to-target (T2T) approach based on faecal calprotectin (FC) ...
Medscape

Case: Probiotics for Ulcerative Colitis?

You are caring for a 45-year-old woman with a 2-year history of mild ulcerative proctosigmoiditis that began at a time of significant stress associated with the breakup of her marriage. The patient ...
Pharmabiz

MRM Health receives US FDA IND clearance to initiate phase 2b trial of MH002 in mild-to-moderate ulcerative colitis

MRM Health receives US FDA IND clearance to initiate phase 2b trial of MH002 in mild-to-moderate ulcerative colitis: Ghent, Belgium Saturday, January 10, 2026, 16:00 Hrs [IST] MRM ...
clinicaladvisor.com

Guideline Issued for Treatment of Mild, Moderate Ulcerative Colitis

A colon affected by ulcerative colitis with massive pseudopolyps. A new clinical guideline from the American Gastroenterological Association focuses on the medical management of patients with ...